Nawsherwan Mohammad: Hypercoagulability and Pulmonary Hypertension in Beta Thalassemia
Nawsherwan (Nawsherwan Sadiq Al Jabari) Mohammad, Consultant Hematopathologist at Nanakaly Hospital, shared a post on LinkedIn about a recent article by Eman M. Mansory et al, published in Iraqi Journal of Hematology, adding:
“Excited to share our latest published research in the Iraqi Journal of Hematology!
In our new study, ‘Study of platelet activation, hypercoagulable state, and pulmonary hypertension in patients with transfusion dependent beta thalassemia, we investigated the underlying pathophysiological mechanisms connecting iron overload, chronic anemia, and prothrombotic risk in transfusion dependent beta thalassemia (TDT).
Comparing 50 TDT patients with 50 healthy controls, our findings highlight significant platelet hyperreactivity (marked by elevated P selectin) and a pronounced depletion of natural anticoagulants like Protein C and Antithrombin III, strongly driven by hepatic iron toxicity and severe hemolysis.
These chronic hemostatic and endothelial alterations directly contribute to pulmonary microvascular thrombosis, paving the way for pulmonary arterial hypertension.
Our work underscores the clinical necessity of comprehensive patient management combining optimal iron chelation, routine coagulation monitoring, and timely vascular risk assessment to prevent life threatening cardiopulmonary complications.”
Title: Safety and efficacy of low-molecular-weight heparin in patients with acute venous thromboembolism postthrombolytic therapy as compared to unfractionated heparin: A systematic review and meta-analysis
Authors: Eman M. Mansory, Maha S. Al-Kathiry, Abdulelah Alzahrani
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 7, 2026, 05:45Andrew Davies: HIDDEN 2 Rethinking Thromboprophylaxis in Hospice Care
-
Nov 7, 2026, 05:32Cancer, Catheters and Outcomes in Upper Extremity DVT – JTH
-
Nov 7, 2026, 02:57Abdelghani Mazouzi: SMIM1 Links Hemoglobin Internalization to Cellular Iron Metabolism
-
Nov 7, 2026, 02:34Ali Moradi: Two Network Meta-Analyses on Cardiovascular Therapies to Be Presented at AHA 2026
-
Nov 7, 2026, 02:21Amit Mohan: Microfluidic Technology Advances the Assessment of Biomaterial-Induced Thrombosis
-
Nov 7, 2026, 02:06Chaza Alaji: The Prothrombotic and Hemorrhagic Spectrum of Tuberculosis
-
Nov 6, 2026, 22:54Vincenzo De Angelis: Presenting Trends and Challenges in Blood and Plasma Collection and Use in Europe
-
Nov 6, 2026, 22:50Alexis Caulier: Leveraging Epigenetic Silencing in HSCs to Modulate Platelet Aggregation
-
Nov 6, 2026, 22:40Panama Achieves Self-Sufficiency in Haemophilia Care – Novo Nordisk Haemophilia and Haemoglobinopathies Foundation